UAB "Tolifarma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 6,800 |
| 6,800 |
| 30,217 |
| -30,217 |
| -30,217 |
| -443.91 |
| -444.37 |
| 35,913 |
| 219 |
| 30,009 |
| 6,123 |
| 0.87 |
| 0.01 |
| -215.54 |
| -14,657 |
| -443.91 |
| -30,186 |
| 2024 |
|---|
| 1,180 |
| 1,180 |
| 15,609 |
| -15,609 |
| -15,609 |
| -1,949.75 |
| -1,322.80 |
| 20,304 |
| 382 |
| 9,722 |
| 10,964 |
| 8.97 |
| 0.02 |
| -795.17 |
| -9,383 |
| -1,949.75 |
| -23,007 |
| 2025 |
|---|
| 0 |
| 0 |
| 6,429 |
| -6,429 |
| -6,429 |
| - |
| - |
| 13,875 |
| 219 |
| 0 |
| 14,094 |
| - |
| 0.02 |
| - |
| -10,080 |
| - |
| -11,918 |
| 2025 |
|---|
| 0 |
| 0 |
| 6,429 |
| -6,429 |
| -6,429 |
| - |
| - |
| 13,875 |
| 219 |
| 0 |
| 14,094 |
| - |
| 0.02 |
| - |
| -10,080 |
| - |
| -11,918 |
Turnover (€)
2025
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
6,429 €-59 % *
Net Profit (€)
-6,429 €59 % *
Profit per employee (€)
-6,429 €59 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
13,875 €-32 % *
Amounts Payable And Liabilities (€)
219 €-43 % *
Non-current Assets (€)
0 €-100 % *
CurrentAssets (€)
14,094 €29 % *
Working capital requirement
-Debt-to-equity ratio
0.02 0.00 % *
EBITDA margin (%)
-EBITDA (€)
-10,080 €-7 % *
EBIT margin (%)
-EBIT (€)
-11,918 €48 % *
